// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Modifiable Barriers in Decision Making Around Living Donor Kidney Transplantation – A Rapid Scoping Review to Guide (DEAL-KD) Study

A. Ahmed - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes of Simultaneous Pancreas-Kidney Transplants from Donation After Circulatory Death Donors in the UK: A National Registry Analysis

N. Karydis - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Paired Surveillance Biopsies Over >4 Years from a Multi-Center Cohort of 78 Long-Term Pediatric Liver Transplant Recipients

E. R. Perito - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune hepatitis

N/A

Pathways and Factors That Confer Therapeutic Properties of Adipose Derived Regenerative Cells in Reducing Ischaemia Reperfusion Injury in Kidney Transplantation

R. Lathan - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

Patterns and Inhibition of Cell Death During Static Cold Storage of Human Kidneys

J. R. DiRito - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Profile of SARS-CoV-2 Antibodies in Patients Awaiting Kidney Transplantation

L. Muir - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Screening, Management and Acceptance of Patients with Aortoiliac Vascular Disease for Kidney Transplantation: An International Survey Among Transplant Surgeons

E. Rijkse - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis

J. Kumar - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The Implications of Donor-Recipient Size Mismatch in Renal Transplantation

I. D. Kostakis - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Delayed graft function

N/A

Versatile Strategy to Enhance Nanomedicine Delivery to Graft Endothelial Cells

C. Albert - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cysteine Hydrochloride

‘In It Together’: including carers to improve outcomes for people with Parkinson’s

K. Mcewan - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

“I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

P. Hobson - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Parkinson's disease

N/A

A Computer-Vision Based Method for Quantifying Parkinsonian Gait

S. Rupprechter - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

A National Data-Linkage Study of Incidence and Prevalence of Primary Dystonia

G. Bailey - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dystonia

N/A

A qualitative evaluation of the health-related quality of life impact on informal caregivers to patients with neurogenic orthostatic hypotension

K. Gallop - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Lewy body dementia

N/A

A retrospective review of clinical and MRI/CT radiological correlation in progressive supranuclear palsy (PSP)

T. Wongwarawipat - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Progressive supranuclear palsy

Levodopa

A retrospective review of clinical features of Progressive Supranuclear Palsy (PSP) in a movement disorders clinic

G. Shepherd - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Progressive supranuclear palsy

Levodopa

An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series

D. Lux - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Corticobasal Syndrome

N/A

Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

M. Peres - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial

J. Greenland - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Oraprine

Copyright © 2026. QuantiNova All rights reserved